학술논문
In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)- 2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor α5 subtype-selective inverse agonist
Document Type
Article
Author
Atack, J.R.; Maubach, K.A.; Wafford, K.A.; O'Connor, D.; Evans, D.C.; Tattersall, F.D.; Chambers, M.S.; MacLeod, A.M.; McKernan, R.M.; Dawson, G.R.; Eng, W.-S.; Ryan, C.; Hostetler, E.; Sanabria, S.M.; Gibson, R.E.; Krause, S.; Burns, H.D.; Hargreaves, R.J.; Rodrigues, A.D.; Agrawal, N.G.B.; Murphy, M.G.; Gingrich, K.; Musson, D.G.; Petty, K.J.
Source
In: Journal of Pharmacology and Experimental Therapeutics . (Journal of Pharmacology and Experimental Therapeutics, November 2009, 331(2):470-484)
Subject
Language
English
ISSN
00223565
15210103
15210103